Home CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
 

Keywords :   


CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C

2016-01-05 22:22:53| Biotech - Topix.net

Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. CEO Kenneth Frazier, speaking Tuesday at a Goldman Sachs conference of CEOs of health care companies in Boston, also said he expects more approvals and growing sales from new cancer drug Keytruda.

Tags: strong deals cancer drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.09When to recline and how to share armrests: Rules for avoiding a mid-flight row
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
More »